Searchable abstracts of presentations at key conferences in endocrinology

ea0016s17.3 | Thyroid cell biology | ECE2008

Molecular mechanisms of thyroid carcinogenesis: role of the CBX7 gene: Loss of the CBX7 gene.ll

Pallante Pierlorenzo , Federico Antonella , Bianco Mimma , Ferraro Angelo , Troncone Giancarlo , Fusco Alfredo

Using gene expression profiling we found that the CBX7 gene was drastically down-regulated in six thyroid carcinoma cell lines versus control cells. This suggested that CBX7 is an oncosuppressor. The aim of this study was to determine whether CBX7 is related to thyroid cancer phenotype, and to try to identify new tools for the diagnosis and prognosis of thyroid cancer. We thus evaluated CBX7 expression in various snap-frozen and paraffin-embedded thyroid carcinoma tissues of d...

ea0092ps1-09-04 | Thyroid Cancer | ETA2023

Development and pre-clinical validation of next-generation sequencing gene panel to detect clinically relevant mutations in thyroid cytological and histological samples

Nacchio Mariantonia , Ingenito Maria , Salatiello Maria , Vigliar Elena , Malapelle Umberto , Troncone Giancarlo , Bellevicine Claudio

Objectives: Molecular techniques are becoming increasingly important for the management of thyroid nodules. In particular, next-generation sequencing (NGS) can assess multiple predictive biomarkers simultaneously, enabling more accurate pre-operative risk stratification for patients with indeterminate fine-needle aspirates and identifying specific molecular alterations for targeted therapy in patients affected by advanced, radioactive iodine refractory carcinomas. To meet thes...

ea0049ep1407 | Thyroid (non-cancer) | ECE2017

Histologically-proven Hashimoto’s thyroiditis significantly decreases the risk of structural recurrence in patients with low risk intra-thyroidal papillary thyroid cancer

Marotta Vincenzo , Sciammarella Concetta , Chiofalo Maria Grazia , Gambardella Claudio , Bellevicine Claudio , Grasso Marica , Conzo Giovanni , Botti Gerardo , Losito Simona , Troncone Giancarlo , Pezzullo Luciano , Colao Annamaria , Faggiano Antongiulio

Introduction: Due to the absence of randomized controlled trials, management of low risk papillary thyroid cancer (PTC), which represents the most commonly diagnosed form of thyroid malignancy, remains controversial. Hashimoto’s thyroiditis (HT) is significantly more frequent in patients with PTC, as compared with subjects carrying benign lesions as well as different tumour histotypes. Despite still controversial, HT is considered a protective factor in PTC being associat...